RxDoctor Payments Data

Mihaela Boran, MD

Psychiatry · Derby, CTNPI 1427058478

Payments from drug & device makers

$2,290in general payments, 2019–2025

Across 151 payments — averaging $15.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Alkermes, Inc.$418
  • Teva Pharmaceuticals USA, Inc.$302
  • Vanda Pharmaceuticals Inc.$72
  • Axsome Therapeutics, Inc.$49
  • Luye Pharma (USA) Ltd.$40
  • plus $115 from 5 others

What the payments were for

  • Food & beverage$2,17995%
  • Education$1115%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,290 in reported general payments places this provider in the 80th percentile of 644 psychiatry providers in Connecticut.

See all psychiatry providers in Connecticut

Medicare billing

Part B allowed, 2024
$38,866
Medicare patients
133
Services billed
617

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine27$169,074
VraylarCariprazine Hcl33$55,832
RexultiBrexpiprazole19$27,768
LybalviOlanzapine/Samidorphan Malate11$19,472
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl58$15,391
Gabapentin154$2,747
Quetiapine Fumarate128$2,435
Aripiprazole27$2,220
Oxcarbazepine18$1,905
Doxepin Hcl40$1,807
Olanzapine31$1,793
Bupropion XlBupropion Hcl133$1,663
Thiothixene12$1,594
Paliperidone ErPaliperidone14$1,497
Clonazepam98$1,104

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$302$169,07427 claims
AbbVieVraylar$1,293$55,83233 claims
Otsuka America Pharmaceutical, Inc.Rexulti$25$27,76819 claims
Alkermes, Inc.Lybalvi$418$19,47211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 644 psychiatry providers in Connecticut.

Other psychiatry in Derby

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →